Metronidazole 1% / Mupirocin 2%
Product Images NDC 72934-5144

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metronidazole 1% / Mupirocin 2% (NDC 72934-5144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ed (2 End)

Partial label on a white plastic container for METRONIDAZOLE 1% / MUPIROCIN 2%, manufactured by Sincerus Florida, LLC. Visible text includes directions for use, contact information for adverse reaction reporting, and storage instructions at controlled room temperature (20-25°C). A QR code is present at the bottom of the label.*

FDA Label Image

X (5144 2 Front)

METRONIDAZOLE 1% / MUPIROCIN 2% ointment in a 30 gram white container with a label showing the product name, strength, and NDC 72934-5144-2. The label includes the Sincerus Florida logo and states that it is a compounded drug made in the USA.*

FDA Label Image

W (5144 2 Middle)

Partial label of METRONIDAZOLE 1% / MUPIROCIN 2% ointment bottle showing active ingredients Metronidazole USP 1% and Mupirocin USP 2%, with inactive ingredient Petrolatum at 97%. The label also includes Lot number, manufacturing date, and a Best Use Date of 01/01/1970. The labeler is Sincerus Florida, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.